Neisler (India) Pharmaceuticals Pvt Ltd - Company Profile

It is a chemicals private limited company based in U T, Chandigarh, India, established in 1993.
1993 U T, Chandigarh, India Struck Off
Last Updated:
Access Report
About Neisler (India) Pharmaceuticals Pvt Ltd

Neisler (India) Pharmaceuticals Pvt Ltd, a struck off private limited company, was established on 25 August 1993 in U T, Chandigarh, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24231CH1993PTC013645. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

Its leadership includes Sanjay Khanna (Director), Sanjeev Khanna (Director). Its latest AGM occurred on 29 September 2007, with the balance sheet filed on 31 March 2007. It is based at # 542Sector 18 Chandigarh, U T, Chandigarh, 160022.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231CH1993PTC013645

  • Registration Number

    013645

  • Incorporation Date

    25 August 1993

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Chandigarh

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 32 Year, 5 Months
  • Last Filing with ROC 31 Mar 2007
Company report

Neisler (India) Pharmaceuticals Pvt Ltd

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Neisler (India) Pharmaceuticals Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Neisler (India) Pharmaceuticals Pvt Ltd?
Current Directors
Name Designation Appointment Date Status
Sanjay Khanna Director 15 Jan 2007 Current
Sanjeev Khanna Director 25 Aug 1993 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Neisler (India) Pharmaceuticals.

Enhance accessibility to Neisler (India) Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Neisler (India) Pharmaceuticals revenue growth over time
Neisler (India) Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Neisler (India) Pharmaceuticals?

Unlock access to Neisler (India) Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Neisler (India) Pharmaceuticals?

Unlock and access historical data on people associated with Neisler (India) Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Neisler (India) Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neisler (India) Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Neisler (India) Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Neisler (India) Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 29 Sep 2007 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Neisler (India) Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2007 with Roc Chandigarh. was documented.

  • Director Appointment

    The activity Sanjay Khanna was appointed as a Director was appointed as a Director on 15 Jan 2007 & has been associated with this company since 19 years 1 month . was completed.

  • Director Appointment

    The activity Sanjeev Khanna was appointed as a Director was appointed as a Director on 25 Aug 1993 & has been associated with this company since 32 years 5 months . was completed.

  • Company Incorporation

    The activity Neisler (India) Pharmaceuticals Pvt Ltd was registered on 25 Aug 1993 with Roc Chandigarh & aged 32 years 5 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Neisler (India) Pharmaceuticals Pvt Ltd?

The CIN of Neisler (India) Pharmaceuticals Pvt Ltd is U24231CH1993PTC013645.

Where is Neisler (India) Pharmaceuticals Pvt Ltd headquartered?

Neisler (India) Pharmaceuticals Pvt Ltd is headquartered at # 542Sector 18 Chandigarh, U T, Chandigarh, 160022.

When was Neisler (India) Pharmaceuticals Pvt Ltd incorporated?

Neisler (India) Pharmaceuticals Pvt Ltd was incorporated on 25 August 1993.

Who are the current directors of Neisler (India) Pharmaceuticals Pvt Ltd?

The current directors of Neisler (India) Pharmaceuticals Pvt Ltd are

What is the primary industry of Neisler (India) Pharmaceuticals Pvt Ltd?

The primary industry of Neisler (India) Pharmaceuticals Pvt Ltd is Chemicals.

Is Neisler (India) Pharmaceuticals Pvt Ltd a listed company?

Neisler (India) Pharmaceuticals Pvt Ltd is unlisted.

What is the capital structure of Neisler (India) Pharmaceuticals Pvt Ltd?

The authorized capital of Neisler (India) Pharmaceuticals Pvt Ltd is ₹0.50 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available